Y. Takase

Early glottic cancer treatment with concurrent chemoradiotherapy with once-daily orally administered S-1

S. Naganawa, K. Ohtakara, Tamami Ono, 2021, Nagoya journal of medical science.

Study Protocol: Prospective Study of Concurrent Chemoradiotherapy with S-1 and Hypofractionated Radiotherapy for Outpatients with Early Glottic Squamous Cell Carcinomas

Tohru Okada, S. Naganawa, Y. Fujimoto, 2018, Asian Pacific journal of cancer prevention : APJCP.

Optimized treatment strategy of radiotherapy for early glottic squamous cell carcinomas: An initial analysis

Tohru Okada, S. Naganawa, Y. Fujimoto, 2017, Nagoya journal of medical science.

Poor local control of ulcerative T1 glottic cancer treated with 2.25-Gy per fraction radiotherapy

S. Naganawa, F. Kinoshita, Y. Itoh, 2021, Nagoya journal of medical science.

Comparison of Physician-recorded Toxicities and Patient-reported Outcomes of Five Different Radiotherapy Methods for Prostate Cancer

Y. Yoshioka, E. Tanaka, Makoto Ito, 2021, AntiCancer Research.

Stereotactic body radiation therapy for prostate cancer: a study comparing 3-year genitourinary toxicity between CyberKnife and volumetric-modulated arc therapy by propensity score analysis

Y. Yoshioka, T. Okuda, Y. Oshima, 2023, Radiation Oncology.

The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments

Y. Shibamoto, S. Naganawa, F. Kikkawa, 2020, BMC Cancer.

Stereotactic body radiation therapy for Japanese patients with localized prostate cancer: 2-year results and predictive factors for acute genitourinary toxicities.

K. Ohtakara, Y. Yoshioka, Makoto Ito, 2021, Japanese journal of clinical oncology.

Optimized radiotherapy treatment strategy for early glottic carcinoma

S. Naganawa, Tamami Ono, Y. Itoh, 2023, Nagoya journal of medical science.